OSLM
Outcome Studies
in Laboratory Medicine
guest
👤
Learn more about this platform
c
Categories
p
Projects
Highlighted
Trial protocol
Study Design
RCT
Cluster RCT
Observational
Model
Meta-analysis
Review
Guideline
Outcomes
Change patient management
Clinical outcomes
Economics
Operational efficiencies
Patient-centeredness
Safety
Guide Policy Making
Other
Uncategorized
Antibiotic Guidance
ACT Guided Heparinization
Cancer
COVID-19
Cardiovascular Disease
Diabetes
HIV POCT
Inflammatory Bowel Disease
Liver Disease
Kidney Disease
Newborn Screening
MALDI-TOF MS For Microorganism Identification
Preeclampsia
Pharmacogenetic and Pharmacogenomics
Therapeutic drug monitoring
Viscoelastic Testing
Please contact us for any suggestions
Zhen Zhao
Smeralda Skenderaj
Search
Search
Categories:
Clinical outcomes
Change patient management
451 Publications
found
Profiling of circulating tumor DNA and tumor tissue for treatment selection in patients with advanced and refractory carcinoma: a prospective, two-stage phase II Individualized Cancer Treatment trial.
b
Therapeutic advances in medical oncology
January 1, 2021
p
Cancer
c
Change patient management
Clinical outcomes
Observational
A Phase II Trial of Osimertinib as the First-Line Treatment of Non-Small Cell Lung Cancer Harboring Activating EGFR Mutations in Circulating Tumor DNA: LiquidLung-O-Cohort 1.
b
Cancer research and treatment
January 1, 2021
p
Cancer
c
Change patient management
Clinical outcomes
Observational
Time in blood glucose range 70 to 180 mg/dL and survival rate in critically ill patients: A retrospective cohort study.
b
PloS one
January 1, 2021
p
Diabetes
c
Change patient management
Clinical outcomes
Observational
Cost-effectiveness of financial incentives to improve glycemic control in adults with diabetes: A pilot randomized controlled trial.
b
PloS one
January 1, 2021
p
Diabetes
c
Change patient management
Clinical outcomes
Economics
RCT
Continuous glucose monitoring for the prevention of morbidity and mortality in preterm infants.
b
The Cochrane database of systematic reviews
December 21, 2020
p
Diabetes
c
Change patient management
Clinical outcomes
Meta-analysis
RCT
Osimertinib for patients with poor performance status and EGFR T790M mutation-positive advanced non-small cell lung cancer: a phase II clinical trial.
b
Investigational new drugs
December 1, 2020
p
Cancer
c
Change patient management
Clinical outcomes
Observational
Biomarkers of Osimertinib Response in Patients with Refractory, EGFR-T790M-positive Non-Small Cell Lung Cancer and Central Nervous System Metastases: The APOLLO Study.
b
Clinical cancer research : an official journal of the American Association for Cancer Research
December 1, 2020
p
Cancer
c
Change patient management
Clinical outcomes
Observational
Clinical Impact of Plasma and Tissue Next-Generation Sequencing in Advanced Non-Small Cell Lung Cancer: A Real-World Experience.
b
The oncologist
December 1, 2020
p
Cancer
c
Change patient management
Clinical outcomes
Observational
Site-Specific and Targeted Therapy Based on Molecular Profiling by Next-Generation Sequencing for Cancer of Unknown Primary Site: A Nonrandomized Phase 2 Clinical Trial.
b
JAMA oncology
December 1, 2020
p
Cancer
c
Change patient management
Clinical outcomes
Observational
Biomarker-driven therapies for previously treated squamous non-small-cell lung cancer (Lung-MAP SWOG S1400): a biomarker-driven master protocol.
b
The Lancet. Oncology
December 1, 2020
p
Cancer
c
Change patient management
Clinical outcomes
Highlighted
Observational
Previous Page
1
…
15
16
17
18
19
…
46
Next Page